Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9561 - 9568 of 12011 results
2015 Employment Law Issues Tournament: Final Four Results and Recap
April 3, 2015| Blog| Viewpoint
FDA Denies Request to Make “Patent Dance” a Prerequisite for Biosimilar Approval
April 3, 2015| Blog| Viewpoint
CMS Issues Proposed Rule on Stage 3 of Meaningful Use
April 3, 2015| Blog| Viewpoint
SEC Announces Action Against Company for Using Confidentiality Agreements That Allegedly Could Deter Whistleblowers
April 2, 2015| Blog| Viewpoint
3 Key Take Aways from AHLA’s Institute on Medicare and Medicaid Payment Issues
April 2, 2015| Blog| Viewpoint
Divided Supreme Court Restricts Provider Challenges to State Medicaid Rates
April 2, 2015| Blog| Viewpoint
New York’s Surprise Medical Bill Law Goes into Effect
April 2, 2015| Blog| Viewpoint
2015 Employment Law Issues Tournament: Elite Eight Results and Recaps
April 1, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|